+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dextroamphetamine"

From
Analyzing the Global CNS Market 2018 - Product Thumbnail Image

Analyzing the Global CNS Market 2018

  • Report
  • April 2018
  • Global
From
From
From
From
From
From
  • 12 Results (Page 1 of 1)
Loading Indicator

Dextroamphetamine is a central nervous system (CNS) stimulant drug used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used off-label to treat depression, obesity, and other conditions. Dextroamphetamine works by increasing the activity of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which can improve focus and alertness. It is available in both immediate-release and extended-release formulations. Common side effects include insomnia, dry mouth, and loss of appetite. Dextroamphetamine is a widely prescribed CNS drug, with millions of prescriptions written each year. It is available in both generic and brand-name formulations, and is covered by most insurance plans. It is also available in combination with other drugs, such as amphetamine and lisdexamfetamine. Some companies in the dextroamphetamine market include Shire Pharmaceuticals, Actavis, Teva Pharmaceuticals, and Mylan. Show Less Read more